Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Why Beating Heart Disease is Everybody’s Fight

Heart disease is the #1 killer of Americans. Despite increased awareness, many Americans don’t know this staggering fact. At The American Heart Association (AHA), the goal is to change the public understanding of heart disease and stroke, and fortify Americans with the knowledge to prevent and treat it. At the heart (pun intended) of this…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

Heart disease is the #1 killer of Americans. Despite increased awareness, many Americans don’t know this staggering fact. At The American Heart Association (AHA), the goal is to change the public understanding of heart disease and stroke, and fortify Americans with the knowledge to prevent and treat it. At the heart (pun intended) of this episode of “I Don’t Care,” host Kevin Stevenson explores the mission, history, and accomplishments of AHA with guest Michelle Stoddard, regional vice president for the American Heart Association in Texas.

At AHA, the organization is driven by a powerful mission: “Be a relentless force for a world of longer, healthier lives.” As the oldest and largest voluntary association dedicated to fighting heart disease and stroke, the AHA has been instrumental in funding discoveries in heart disease research. Stoddard explains, anyone who has benefited from a heart valve, cholesterol-lowering drugs, CPR, or open-heart surgery, has been directly affected by AHA’s research.

Without question, AHA’s research has saved lives, which makes its fundraising efforts all the more important. Stoddard expounds upon AHA programs that have helped educate and raise money to perpetuate their mission such as “Get with the Guidelines,” “Go Red for Women,” “Healthy for Life,” and the upcoming “Heart Walk.” This annual community event will take place in Waco, TX on October 3. The walk may look different this year, Stoddard explains, but she encourages everyone to “sign up, lace up,” and get out and walk for their health, be it virtually or safely within the community.

Visit heart.org for more resources on how to fight heart disease and stroke.

Catch up on previous episodes of I Don’t Care with Kevin Stevenson!

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub